Oct 16 |
Wave stock soars 66% on positive data for RNA editing treatment (update)
|
Oct 16 |
GSK antibiotic for UTI accepted for FDA priority review
|
Oct 15 |
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
|
Oct 15 |
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
|
Oct 14 |
GSK reports positive Phase 3 results for nasal drug depemokimab
|
Oct 14 |
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
|
Oct 11 |
Jim Cramer Says GSK plc (GSK) ‘Goes Higher’
|
Oct 10 |
GSK: The Worst Is Finally Over (Rating Upgrade)
|
Oct 10 |
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
|
Oct 10 |
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
|